Cleveland Clinic adopts CTVQ
Filed with ASX · · 2 pages · English
Summary by 6ix AI
4DMedical Ltd. announces that Cleveland Clinic has commenced clinical use of its CT:VQ™ technology, marking a significant milestone for the company. Cleveland Clinic is now the third major U.S. academic medical center to adopt CT:VQ™, following Stanford and University of Miami, within three months of FDA clearance. The arrangement includes an introductory pricing period to facilitate integration into clinical workflows before transitioning to full commercial terms. This deployment is expected to serve as a critical reference site, showcasing the clinical utility of CT:VQ™ to the broader U.S. hospital market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from 4DMedical
- 4DMedical secures regulatory approval for CTVQ in Canada
- 4DMedical secures $30.2 million with options underwrite
- University of Miami adopts CTVQ
- 4DMedical secures US$10m CTVQ orders in Philips deal
- CTVQ commercial rollout commences at Stanford
Later from 4DMedical
- UC San Diego Health adopts CTVQ
- Trading Halt
- 4DMedical completes $150 million institutional placement
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
- Quarterly Activity Report and Appendix 4C
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical